Comparison of N-glycan pattern of recombinant human coagulation factors II and IX expressed in Chinese hamster ovary (CHO) and African green monkey (Vero) cells

Kurachi K. Recombinant antihemophilic factors. In: Goldstein J, ed. Biotechnology of Blood. Boston: Butterworth-Heinemann, 1992:177–195.

Goodey AR. The production of heterologous plasma proteins. Trends Biotechnol 1993;11:430–433.

Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1993;53:505–518.

Cumming DA. Physiological relevance of protein glycosylation. Dev Biol Stand 1992;76:83–94.

Geisow MJ. Glycoprotein glycans—roles and control. Trends Biotechnol 1992;10:333–335.

Rademacher TW. Glycosylation as a factor affecting product consistency. Biologicals 1993;21:103–104.

Werner RG, Noe W. Mammalian cell cultures. Genetic engineering, protein glycosylation, fermentation and process control. Drug Res 1993;43:1242–1249.

Yan SCB, Grinnell B, Wold F. Post-translational modifications of proteins. Trends Biol Sci 1989;14:264–268.

Fischer B, Mitterer A, Dorner F. Purification of recombinant human coagulation factors II and IX and protein S expressed in recombinant Vaccinia virus-infected Vero cells. J Biotechnol 1995;38:129–136.

Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.

Laemmli UK. Cleavage o structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.

Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci USA 1979;76:4350–4354.

Paulson JC. Glycoproteins: What are the sugar chains for? Trends Biol Sci 1989;14:272–276.

Warren CE. Glycosylation. Curr Opin Biotechnol 1993;4:596–602.